The global inhaled therapy in respiratory disease market size was valued at USD 11.58 billion in 2024 and is predicted to hit around USD 16.22 billion by 2034, rising at a 3.44% CAGR, a study published by Towards Healthcare a sister firm of Precedence Researc…
Zdroj: 📰 GlobeNewswire
| 